martes, 6 de octubre de 2026
BuscarExplore
Via News Knowledge File

Intel Corporation

organization80% conf.·synced Oct 6, 2026

CPU competitor to AMD

60
sourced metrics
1172
relationships
20
stated objectives
8
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Price 52 Week High
140.94USD
Oct 5, 2026reference only
Price 52 Week Low
33.62USD
Oct 5, 2026reference only
Stock Price
116.19USD
Oct 5, 2026reference only
Market Cap
586062360000USD
Oct 5, 2026reference only
Stock Return Ytd
195.0%
Oct 5, 2026reference only
Shares Outstanding
5044000000.0shares
Jul 17, 2026reference only
Rd Expense
3368000000.0USD
Jun 27, 2026reference only
Net Income
-11033000000.0USD
Jun 27, 2026reference only
Gross Profit
6509000000.0USD
Jun 27, 2026reference only
Cash
12874000000.0USD
Jun 27, 2026reference only
Revenue
16128000000.0USD
Jun 27, 2026reference only
Operating Income
1796000000.0USD
Jun 27, 2026reference only
Eps
-2.16USD_per_share
Jun 27, 2026reference only
Stockholders Equity
87542000000.0USD
Jun 27, 2026reference only
Total Assets
202439000000.0USD
Jun 27, 2026reference only
Cost Of Revenue
9619000000.0USD
Jun 27, 2026reference only
Operating Cash Flow
1096000000.0USD
Mar 28, 2026reference only
Capex
3636000000.0USD
Mar 28, 2026reference only

Stated objectives

Reduce OpEx to $16B for full year 2026

source
target: 16 billion USD by 2026-12-31 00:00:00stated

Achieve positive adjusted free cash flow for full year 2026

source
target: positive by 2026-12-31 00:00:00stated

Achieve 7-8% per month yield improvements focusing on variation, consistency, defect density

source
target: 7-8% monthly by 2026-01-01 00:00:00stated

Secure firm customer commitments for Intel 14A manufacturing

source
by 2027-06-30 00:00:00stated

Begin Intel 14A risk production

source
by 2027-12-31 00:00:00stated

Begin Intel 14A volume production

source
by 2028-01-01 00:00:00stated

Launch Nova Lake client processor

source
by 2026-12-31 00:00:00stated

Begin advanced packaging customer ramps

source
by 2026-09-30 00:00:00stated

Improve supply constraints each quarter through 2026 starting Q2

source
target: above seasonal growth by 2026-12-31 00:00:00stated

Q1 2026 revenue guidance

source
target: 11.7-12.7 billion USD by 2026-03-31 00:00:00stated

Relationship graph · 1172 connections

Competes with
307
Supplies to
192
Developed by
167
Covered by
95
Customer of
73
Employs
67
Invested in
49
subsidiary of
41

Via News coverage

This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com